Qyuns Therapeutics (02509) Announces Share Repurchase and Updated Shareholding
Bulletin Express
Nov 19
Qyuns Therapeutics (02509) submitted a Next Day Disclosure Return on 19 November 2025, reporting a repurchase of 97,200 H shares on the Stock Exchange on 19 November 2025. Following this transaction, the total issued shares excluding treasury shares stood at 226,289,000, while treasury shares increased to 782,600.
According to the disclosed information, the repurchased shares remain held as treasury shares, and the aggregate consideration for the repurchase was approximately HKD 1,996,206.12. Under the current repurchase mandate, the moratorium period on issuing new shares or disposing of treasury shares will last until 19 December 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.